Values of Cytokines and Tryptophan Metabolites over a 12 Weeks Time Course in Patients with Depression and Somatoform Disorder.

Cytokines Depression Kynurenic acid Kynurenine Somatoform disorders Tryptophan

Journal

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
ISSN: 1738-1088
Titre abrégé: Clin Psychopharmacol Neurosci
Pays: Korea (South)
ID NLM: 101207332

Informations de publication

Date de publication:
28 Feb 2019
Historique:
received: 24 04 2017
revised: 31 08 2017
accepted: 24 10 2017
entrez: 29 1 2019
pubmed: 29 1 2019
medline: 29 1 2019
Statut: ppublish

Résumé

Previous studies have suggested alterations in the kynurenine pathway as a major link between cytokine and neurotransmitter abnormalities in psychiatric disorders. Most of these studies used a cross-sectional case-control study design. However, knowledge is still lacking regarding the stability over time of kynurenine pathway metabolites and the functionally related cytokines. Therefore, we studied the stability of cytokines and tryptophan (TRP) parameters over a period of 12 weeks. A total of 117 participants-39 with major depression, 27 with somatoform disorder, and 51 healthy controls were enrolled. Four evaluations, including blood withdrawal and psychometric testing, were performed over a period of 12 weeks. We used ELISA to measure interleukin (IL)-6, IL-1 receptor antagonist (RA) and tumor necrosis factor α (TNF α). High-performance liquid chromatography was used to analyze neurotransmitter variables, i.e. TRP, 5-hydroxyindoleacetic acid (5-HIAA), kynurenine (KYN), 3-OH-kynurenine (3-HK), and kynurenic acid (KYNA). We found no significant fluctuations of TRP, its metabolites (5-HIAA, KYN, KYNA, and 3-HK), or the cytokines (IL-1RA, IL-6, and TNF α) in any of the groups over the 12 weeks. To our knowledge, this is the first longitudinal study performed in psychiatric patients to verify the stability and consequently the reliability of the biological parameters we investigated. Our data indicate that TRP metabolites and cytokines are reliable biological parameters in psychiatric research because they do not fluctuate significantly over time.

Identifiants

pubmed: 30690938
pii: cpn.2019.17.1.34
doi: 10.9758/cpn.2019.17.1.34
pmc: PMC6361033
doi:

Types de publication

Journal Article

Langues

eng

Pagination

34-42

Références

Soz Praventivmed. 1999;44(2):55-64
pubmed: 10407953
J Psychosom Res. 1999 Jun;46(6):507-18
pubmed: 10454165
Eur Arch Psychiatry Clin Neurosci. 2001;251(2):90-7
pubmed: 11407444
J Clin Endocrinol Metab. 2002 Mar;87(3):1184-8
pubmed: 11889184
Mol Psychiatry. 2002;7(5):468-73
pubmed: 12082564
Mol Psychiatry. 2005 Jun;10(6):538-44
pubmed: 15494706
Am J Psychiatry. 2006 Apr;163(4):746-7; author reply 747-8
pubmed: 16585456
Soc Psychiatry Psychiatr Epidemiol. 2006 Sep;41(9):704-12
pubmed: 16794766
Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1291-3
pubmed: 17548700
J Mol Med (Berl). 2007 Dec;85(12):1351-9
pubmed: 17594069
Neuroimmunomodulation. 2007;14(5):235-42
pubmed: 18073498
Am J Nephrol. 2008;28(5):808-12
pubmed: 18506106
Psychosom Med. 2009 Feb;71(2):171-86
pubmed: 19188531
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):37-44
pubmed: 19778568
Biol Psychiatry. 2010 Mar 1;67(5):446-57
pubmed: 20015486
J Psychosom Res. 2010 May;68(5):495-502
pubmed: 20403510
Behav Brain Funct. 2010 Jun 09;6:32
pubmed: 20534153
Psychoneuroendocrinology. 2011 Apr;36(3):426-36
pubmed: 21041030
J Affect Disord. 2011 Jun;131(1-3):143-9
pubmed: 21167607
Curr Immunol Rev. 2010 Aug;6(3):205-212
pubmed: 21170282
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):702-21
pubmed: 21185346
PLoS One. 2011;6(6):e21002
pubmed: 21695270
Psychiatry Res. 2012 Jan 30;195(1-2):60-5
pubmed: 21864915
Brain Behav Immun. 2012 Feb;26(2):251-66
pubmed: 21986304
Mol Psychiatry. 2013 May;18(5):595-606
pubmed: 22525486
BMC Med. 2012 Jun 29;10:66
pubmed: 22747645
Acta Psychiatr Scand. 2014 Feb;129(2):83-97
pubmed: 23952563
Physiol Behav. 2015 Feb;139:328-35
pubmed: 25460540
Psychopharmacology (Berl). 2016 May;233(9):1669-78
pubmed: 25877654
Psychoneuroendocrinology. 2016 Oct;72:156-60
pubmed: 27428088
Clin Psychopharmacol Neurosci. 2017 Feb 28;15(1):59-63
pubmed: 28138112
J Nerv Ment Dis. 1989 Mar;177(3):140-6
pubmed: 2918297
BMJ. 1998 Apr 18;316(7139):1236-8
pubmed: 9553006

Auteurs

Daniela Krause (D)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Verena B Kirnich (VB)

Department of Laboratory Medicine, Ludwig Maximilians University, Munich, Germany.

Theresa M Stapf (TM)

Department of Laboratory Medicine, Ludwig Maximilians University, Munich, Germany.

Anika Hennings (A)

Division of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Marburg, Germany.

Sabine Riemer (S)

Division of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Marburg, Germany.

Michael Riedel (M)

Department of Laboratory Medicine, Ludwig Maximilians University, Munich, Germany.

Ralf Schmidmaier (R)

Department of Hematology and Oncology, Ludwig Maximilians University, Munich, Germany.

Francisco Pedrosa Gil (FP)

Department of Psychiatry, Vogtland Hospital, Plauen, Germany.

Winfried Rief (W)

Division of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Marburg, Germany.

Markus J Schwarz (MJ)

Department of Laboratory Medicine, Ludwig Maximilians University, Munich, Germany.

Classifications MeSH